The Assistance publique-Hôpitaux de Marseille and the Méditerranée Infection Foundation have informed the National Agency for the Safety of Medicines and Health Products (ANSM) about a new publication considered problematic by the controversial professor Didier Raoult, according to information from the APHM, Agence France Presse. Thursday, September 5. Confirming information from Spot.
This report follows the publication of an article co-authored by Didier Raoult, former director of the University Hospital Institute (IHU) of Mediterranean Infections in Marseille, and one of his former close collaborators, Philippe Brouqui, in the August 2024 issue of the journal. Acta Scientific Microbiology. This article, which collects data from 1,276 Covid-19 patients treated at the IHU, some of them with hydroxychloroquine, aims to demonstrate once again the efficacy of this controversial treatment promoted by Professor Raoult.
In their letter, the APHM and the Mediterranean Infections Foundation, which oversees the IHU, “report” and “dissociate” of this article whose methodology is based on “Use of patient data and unauthorized research”specified the APHM. According to the establishment, this report was decided in a “logic of returning to normality” at the IHU since the departure of Professor Raoult, now retired.
The ANSM took legal action in November 2023 following the publication of another study co-signed by Professor Raoult, which had not obtained the mandatory authorisations. The former head of the IHU and his team are suspected of having carried out several studies “savages” at the IHU during the SARS-CoV-2 coronavirus epidemic
